Showing 1 - 20 results of 40 for search 'Watson, JA', query time: 0.05s
Refine Results
-
1
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria by Watson, JA, White, NJ
Published 2022Journal article -
2
Is malaria parasite ex-vivo viability reduction really “superior” to observed parasite clearance rate? by White, NJ, Watson, JA
Published 2020Journal article -
3
Questioning the claimed superiority of malaria parasite ex vivo viability reduction over observed parasite clearance rate? by White, NJ, Watson, JA
Published 2020Journal article -
4
The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria by Watson, JA, Peto, TJ, White, NJ
Published 2023Journal article -
5
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria by Watson, JA, Peto, TJ, White, NJ
Published 2023Journal article -
6
Severe malaria, pascalian therapeutics, and the US Food and Drug Administration (FDA) by White, NJ, Watson, JA, Simpson, JA
Published 2022Journal article -
7
Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials by White, NJ, Watson, JA, Baird, JK
Published 2022Journal article -
8
Tafenoquine for the prevention of Plasmodium vivax malaria relapse by Watson, JA, Nekkab, N, White, M
Published 2021Journal article -
9
Falciparum malaria mortality in sub-Saharan Africa in the pretreatment era by Watson, JA, White, NJ, Dondorp, AM
Published 2021Journal article -
10
WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria by Peto, TJ, Watson, JA, White, NJ, Dondorp, AM
Published 2023Journal article -
11
Pharmacometric and electrocardiographic evaluation of chloroquine and azithromycin in healthy volunteers by Chotsiri, P, Tarning, J, Hoglund, RM, Watson, JA, White, NJ
Published 2022Journal article -
12
Characterizing SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies by Watson, JA, Kissler, SM, Day, NPJ, Grad, YH, White, NJ
Published 2022Journal article -
13
Non-adherence in non-inferiority trials: pitfalls and recommendations by Mo, Y, Lim, C, Watson, JA, Nicholas J White, Cooper, BS
Published 2020Journal article -
14
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology by White, NJ, Watson, JA, Hoglund, RM, Chan, XHS, Cheah, PY, Tarning, J
Published 2020Journal article -
15
-
16
Stopping prereferral rectal artesunate - a grave error by Watson, JA, Warsame, M, Peto, TJ, Onyamboko, M, Fanello, C, Dondorp, AM, White, N
Published 2022Journal article -
17
Concentration-dependent mortality of chloroquine in overdose by Watson, JA, Tarning, J, Hoglund, RM, Baud, FJ, Megarbane, B, Clemessy, J-L, White, NJ
Published 2020Journal article -
18
-
19
A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell's viper antivenom in Myanmar by Watson, JA, Lamb, T, Holmes, J, Warrell, DA, Thwin, KT, Aung, ZL, Oo, MZ, Nwe, MT, Smithuis, F, Ashley, EA
Published 2020Journal article -
20